Marine biotechnology and material science convergence is fundamentally transforming packaging capabilities. The integration ...

An energizing, improv-based half-day class designed for professionals who want to think clearly, connect authentically, ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...

While GLP-1 (glucagon-like peptide-1) class obesity treatments like ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, ...

Insilico Medicine has entered into a co-development collaboration agreement with Hygtia Therapeutics, with both parties each holding 50% of the global rights and interests to the program. In return, ...

Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make ...

GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...

The San Francisco-based drugmaker said Tuesday that it plans to double its investment and create an additional 100 jobs at a ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

Under the terms of the agreement, GSK will pay RAPT Therapeutics shareholders $58.00 per share at closing for an estimated ...

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.